Wim E. M. Mol
Director/Miembro de la Junta en Inorbit Therapeutics AB .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Bert Benthem | M | 62 |
Inorbit Therapeutics AB
 Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | - |
| Johannes Bruski | M | - |
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | - |
| Hans-Peter Albert Ostler | M | 53 |
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | - |
| Louise Warme | F | - |
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | - |
| Dominik Höchli | M | 57 |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | 3 años |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Suecia | 4 | 80.00% |
| Países Bajos | 1 | 20.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Wim E. M. Mol
- Red Personal
